882 F.Supp.2d 643 (D.Del. 2012), C. A. 09-cv-307 (GMS), Pfizer Inc. v. Teva Pharmaceuticals U.S.A., Inc.
Linked as:
Extract
882 F.Supp.2d 643 (D.Del. 2012), C. A. 09-cv-307 (GMS), Pfizer Inc. v. Teva Pharmaceuticals U.S.A., Inc.
No longer available (Autolink)
See the full content of this document
This document cites
- Federal Cases - 669 F.Supp.2d 227 (D.Conn. 2009), 3:03cv01382 (WIG), Lamoureux v. AnazaoHealth Corp.
- Federal Cases - 146 F.Supp.2d 572 (D.N.J. 2001), Civ.99-2006, Ben Venue Laboratories, Inc. v. Novartis Pharmaceutical Corp.
- Federal Cases - 405 F.Supp.2d 495 (D.Del. 2005), Civ. A. 03-209, Pfizer, Inc. v. Ranbaxy Laboratories Ltd.
- Federal Cases - 520 F.Supp.2d 537 (D.Del. 2007), C. A. 03-896, Martek Biosciences Corp. v. Nutrinova Inc.
- Federal Cases - 607 F.Supp.2d 614 (D.Del. 2009), C. A. 05-642, Alza Corp. v. Andrx Pharmaceuticals, LLC
